Cercar
01/01/2024
Archivos de Bronconeumologia 59 (2023) 63–65, (S0300289622004975), (10.1016/j.arbres.2022.07.011)
Palones E., Curto E., Pelegrí A., Arilla M., Solanes I., Crespo-Lessmann A.. Archivos de Bronconeumologia 59 (2023) 63–65, (S0300289622004975), (10.1016/j.arbres.2022.07.011). ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.11.007. PMID:38040573. IF:9.200(Q1/1D).
01/01/2024
Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients
Valverde-Monge M., Sánchez-Carrasco P., Betancor D., Barroso B., Rodrigo-Muñoz J.M., Mahillo-Fernández I., Arismendi E., Bobolea I., Cárdaba B., Cruz M.J., Del Pozo V., Domínguez-Ortega J., González-Barcala F.J., Olaguibel J.M., Luna-Porta J.A., Martínez-Rivera C., Mullol J., Muñoz X., Peleteiro-Pedraza L., Picado Valles C., Plaza V., Quirce S., Rial M.J., Soto-Retes L., Valero A., Sastre J.. Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.11.011. PMID:38042707. IF:9.200(Q1/1D).
01/01/2024
Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study
Cano-Jiménez, E, Gómez, AV, Segovia, EV, Barrenechea, MA, Torres, JS, Francesqui, J, Carroz, KP, Solis, AJS, Fernández, OA, González, ABL, Bordas-Martinez, J, Cesar, EC, Vilarnau, EB, Villegas, DC, Pardessus, AR, Fernández, CG, Moyano, MG, Gajate, AU, Hortas, AB, Molina-Molina, M. Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study. Erj Open Research. 2024; 10(1)DOI:10.1183/23120541.00405-2023. PMID:38410707. IF:4.000(Q1/2D).
01/01/2024
Ultrasound in the Study of Thoracic Diseases: Innovative Aspects
Romero, BR, Torrubiano, IV, Juan, JM, Frades, SH, Pallares, JP, Ruiz, VP, Pérez, AW, Ramos, HC, Viedma, EC. Ultrasound in the Study of Thoracic Diseases: Innovative Aspects. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.10.009. PMID:37996336. IF:9.200(Q1/1D).
01/01/2024
Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience
de-Torres, JP, Casanova, C, Marín, JM, Cabrera, C, Marín, M, Ezponda, A, Cosio, BG, Martínez, C, Solanes, I, Fuster, A, Calle, M, Gotera, C, Feu-Collado, N, Marin, A, Alcaide, AB, Sangro, M, Bastarrika, G, Celli, BR. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.10.002. PMID:37925245. IF:9.200(Q1/1D).
01/01/2024
Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort
Betancor, D, Otal, M, Olaguibel, JM, Rodrigo-Muñoz, JM, Puebla, MJA, Arismendi, E, Barranco, P, Barroso, B, Bobolea,, Cárdaba, B, Cruz, MJ, Curto, E, Del Pozo,, Domínguez-Ortega, J, González-Barcala, FJ, Luna-Porta, JA, Martínez-Rivera, C, Mullol, J, Muñoz, X, Picado, C, Plaza,, Quirce, S, Rial, MJ, Roibás-Veiga,, Soto-Retes, L, Valero, A, Valverde-Monge, M, Sastre, J. Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2024; 34(3)DOI:10.18176/jiaci.0966. PMID:38888581. IF:4.800(Q1/1D).
01/01/2024
Use of Triple Therapy in Asthma: The GEMAFORUM V Task Force
Plaza, V, Trigueros, JA, Carretero, JA, Arranz, IO, Chicote, JMV, Sánchez, CA, Tomás, JB, Serrano, CC, Juncal, LD, Domínguez-Ortega, J, Rivero, JF, Campos, JGS, Fernández, EM, Martinez, S, Lacomba, JM, Quirce, S. Use of Triple Therapy in Asthma: The GEMAFORUM V Task Force. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2024; 34(4)DOI:10.18176/jiaci.0975. PMID:38334050. IF:4.800(Q1/1D).
18/12/2023
Bronchoalveolar cytokine profile differentiates Pulmonary Langerhans cell histiocytosis patients from other smoking-related interstitial lung diseases
Barril, S, Acebo, P, Millan-Billi, P, Luque, A, Sibila, O, Tarin, C, Tazi, A, Castillo, D, Hortelano, S. Bronchoalveolar cytokine profile differentiates Pulmonary Langerhans cell histiocytosis patients from other smoking-related interstitial lung diseases. RESPIRATORY RESEARCH. 2023; 24(1)DOI:10.1186/s12931-023-02622-z. PMID:38111019. IF:4.700(Q1/2D).
01/12/2023
Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population
Almonacid-Sánchez C., García-Cosío B., Trisán-Alonso A., Callejas-González F.J., Cisneros C., Martínez-Moragón E., Plaza Moral V., Vera E., Soto-Campos J.G., Martínez-Rivera C., Alcazar-Navarrete B., Urrutia Landa I., García-Rivero J.L., Padilla Galo A., Álvarez-Gutierrez F., Ramos-González J., Carretero-Gracia J.Á., Lluch I., Puente L., Andujar-Espinosa R., Pérez-de-Llano L.. Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(12)DOI:10.1016/j.arbres.2023.08.017. PMID:37865605. IF:8.700(Q1/1D).
01/11/2023
Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA
Plaza, V, Domínguez-Ortega, J, Alsina, DGS, Lo Re, D, Sicras-Mainar, A. Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA. Pharmaceuticals. 2023; 16(11)DOI:10.3390/ph16111609. PMID:38004474. IF:4.300(Q1/2D).
01/01/2023
Pulmonary Complications Following Hematopoietic Stem Cell Transplantation: Radiological Considerations
Franquet T., Giménez A., Mazzini S.. Pulmonary Complications Following Hematopoietic Stem Cell Transplantation: Radiological Considerations. Applied Psychology Readings: Selected Papers From The Singapore Conference On Applied Psychology 2022. 2023; DOI:10.1007/978-3-031-28797-8_6. PMID:. IF:(Q/D).
01/01/2023
Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19
Figueira-Gonçalves, JM, García-Bello, MA, Ramallo-Fariña, Y, Méndez, R, Campos, AL, González-Jiménez, P, Peces-Barba, G, Molina-Molina, M, España, PP, García, E, Domínguez-Pazos, SD, Clemente, MG, Panadero, C, de la Rosa-Carrillo, D, Sibila, O, Martínez-Pitarch, MD, Toledo-Pons, N, López-Ramirez, C, Almonte-Batista, W, Macías-Paredes, A, Redenes-Bonet, D, Pérez-Rodas, EN, Lázaro, J, Fernández, SQ, Cordovilla, R, Cano-Pumarega, I, Torres, A, Menendez, R. Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19. International Journal of Chronic Obstructive Pulmonary Disease. 2023; 18DOI:10.2147/COPD.S428316. PMID:37955022. IF:2.700(Q2/5D).
01/01/2023
Reply to "Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies"
Barroso, B, Valverde-Monge, M, Alobid,, Olaguibel, J, Rial, M, Quirce, S, Arismendi, E, Barranco, P, Betancor, D, Bobolea,, Cardaba, B, Carmona, MC, Curto, E, Dominguez-Ortega, J, Gonzalez-Barcala, F, Martinez-Rivera, C, Mahillo-Fernandez,, Munoz, X, Picado, C, Plaza,, Munoz, JR, Retes, LS, Valero, A, Delpozo,, Mullol, J, Sastre, J. Reply to "Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies". JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(6)DOI:10.18176/jiaci.0953. PMID:38095497. IF:6.700(Q1/2D).
01/08/2022
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019
Fanciulli, C, Berenguer, J, Busca, C, Vivancos, MJ, Tellez, MJ, Dominguez, L, Domingo, P, Navarro, J, Santos, J, Iribarren, JA, Morano, L, Artero, A, Moreno, J, Rivero-Roman, A, Santos, I, Giner, L, Arminanzas, C, Montero, M, Manzardo, C, Cifuentes, C, Garcia, C, Galindo, MJ, Ferrero, OL, Sanz, J, de la Fuente, B, Rodriguez, C, Gaspar, G, Perez, L, Losa, JE, Force, L, Veloso, S, Martinez-Alfaro, E, Jarrin, I, De Miguel, M, Garcia, JG. Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019. HIV MEDICINE. 2022; 23(7)DOI:10.1111/hiv.13229. PMID:35037379. IF:3.000(Q3/7D).
01/07/2022
HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe
Amele, S, Sandri, AK, Rodger, A, Vandekerckhove, L, Benfield, T, Milinkovic, A, Duvivier, C, Stellbrink, HJ, Sambatakou, H, Chkhartishvili, N, Caldeira, L, Laguno, M, Domingo, P, Wandeler, G, Gisinger, M, Kuzovatova, E, Dragovic, G, Knysz, B, Matulionyte, R, Rockstroh, JK, Lundgren, JD, Mocroft, A, Peters, L. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe. HIV MEDICINE. 2022; 23(6)DOI:10.1111/hiv.13212. PMID:34882940. IF:3.000(Q3/7D).
01/07/2022
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study
Mocroft, A, Miro, JM, Wandeler, G, Llibre, JM, Boyd, A, van Bremen, K, Beniowski, M, Mikhalik, J, Cavassini, M, Maltez, F, Duvivier, C, Foppa, CU, Knysz, B, Bakowska, E, Kuzovatova, E, Domingo, P, Zagalo, A, Viard, JP, Degen, O, Milinkovic, A, Benfield, T, Peters, L. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study. HIV MEDICINE. 2022; 23(6)DOI:10.1111/hiv.13210. PMID:34889022. IF:3.000(Q3/7D).
01/02/2022
The endocrine role of brown adipose tissue: An update on actors and actions
Gavalda-Navarro, A, Villarroya, J, Cereijo, R, Giralt, M, Villarroya, F. The endocrine role of brown adipose tissue: An update on actors and actions. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS. 2022; 23(1)DOI:10.1007/s11154-021-09640-6. PMID:33712997. IF:8.200(Q1/1D).
12/01/2022
Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission
Calvet, J, Berenguer-Llergo, A, Gay, M, Massanella, M, Domingo, P, Llop, M, Sanchez-Jimenez, E, Arevalo, M, Carrillo, J, Albinana, N, Arauz-Garofalo, G, Orellana, C, Delgado, JF, Serrano, A, Llobell, A, Graell, E, Garcia-Manrique, M, Moreno, M, Galisteo, C, Casado, E, Navarro, N, Gomez, A, Garcia-Cirera, S, Rusinol, M, Costa, E, Clotet, B, Vilaseca, M, Blanco, J, Gratacos, J. Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-021-04683-w. PMID:35022497. IF:4.600(Q2/4D).
15/11/2021
Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial
Grau-Pujol, B, Camprubi-Ferrer, D, Marti-Soler, H, Fernandez-Pardos, M, Carreras-Abad, C, Velasco-de Andres, M, Ferrer, E, Muelas-Fernandez, M, Jullien, S, Barilaro, G, Ajanovic, S, Vera, I, Moreno, L, Gonzalez-Redondo, E, Cortes-Serra, N, Roldan, M, Artes-de Arcos, A, Mur, I, Domingo, P, Garcia, F, Guinovart, C, Munoz, J. Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial. Trials. 2021; 22(1)DOI:10.1186/s13063-021-05758-9. PMID:34781981. IF:2.728(Q4/8D).
01/11/2021
Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19
Alserawan, L, Penacoba, P, Echevarria, SEO, Castillo, D, Ortiz, E, Martinez-Martinez, L, Naranjo, EM, Domingo, P, Castellvi, I, Juarez, C, Mariscal, A. Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19. Diagnostics. 2021; 11(11)DOI:10.3390/diagnostics11111998. PMID:34829345. IF:3.992(Q2/4D).